Astellas Pharma Inc
XMUN:YPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Astellas Pharma Inc
XMUN:YPH
|
JP |
|
P
|
P&H Tech Co Ltd
KOSDAQ:239890
|
KR |
|
V
|
Vicem Packaging Bimson JSC
VN:BPC
|
VN |
|
G
|
Graycliff Exploration Ltd
CNSX:GRAY
|
CA |
|
S
|
Steel PCL
SET:THE
|
TH |
|
D
|
DigitalOcean Holdings Inc
XBER:0SU
|
US |
|
D
|
Digicann Ventures Inc
CNSX:DCNN
|
CA |
|
A
|
Alternus Energy Group PLC
OSE:ALT
|
IE |
|
P
|
Panasonic Holdings Corp
XHAM:MAT1
|
JP |
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
US |
|
P
|
Proodeftiki Technical Co SA
ATHEX:PRD
|
GR |
|
DocMorris AG
SIX:DOCM
|
CH |
|
F
|
FIH Mobile Ltd
XMUN:FW3
|
TW |
|
S
|
Sonos Inc
SWB:8SO
|
US |
|
R
|
R&B Food Supply PCL
SET:RBF
|
TH |
|
A
|
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
|
KR |
|
C
|
Chagee Holdings Ltd
NASDAQ:CHA
|
CN |
|
P
|
PRG Corporation PCL
SET:PRG
|
TH |
|
A
|
Anglo Pacific Group PLC
TSX:APY
|
UK |
Bankruptcy Probability
Astellas Pharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Astellas Pharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JP |
|
Astellas Pharma Inc
TSE:4503
|
4.3T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
640B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
369.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
185.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
286.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Astellas Pharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Astellas Pharma Inc has total debt of 320B JPY. This includes both short-term (0 JPY) and long-term (320B JPY) debt.
You can find a full breakdown on its Balance Sheet.
